✦ LIBER ✦

Add-On Therapies to Metformin in Type 2 Diabetes: What Modulates the Respective Decrements in Postprandial and Basal Glucose?

✍ Scribed by Monnier, Louis; Colette, Claude; Comenducci, Andrea; Vallée, Denis; Dejager, Sylvie

Book ID: 115491364
Publisher: Mary Ann Liebert
Year: 2012
Tongue: English
Weight: 354 KB
Volume: 14
Category: Article
ISSN: 1520-9156
DOI: 10.1089/dia.2012.0045

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of vildaglipti

Efficacy and tolerability of vildagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes mellitus

✍ C. Pan; X. Xing; P. Han; S. Zheng; J. Ma; J. Liu; X. Lv; J. Lu; G. Bader; on beh 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 683 KB

Safety and efficacy of linagliptin as ad

Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study

✍ M.-R. Taskinen; J. Rosenstock; I. Tamminen; R. Kubiak; S. Patel; K. A. Dugi; H.- 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 797 KB

PDB62 COST-UTILITY ANALYSIS OF SAXAGLIPT

PDB62 COST-UTILITY ANALYSIS OF SAXAGLIPTIN AS AN ADD-ON THERAPY TO METFORMIN IN TYPE 2 DIABETES PATIENTS FROM THE BRAZILIAN PRIVATE HEALTH SYSTEM

✍ FG Eliaschewitz; E Asano; ME Nita; R Rached; BM Donato 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Long-term efficacy and tolerability of a

Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes

✍ B. Charbonnel; G. Schernthaner; P. Brunetti; D. R. Matthews; R. Urquhart; M. H. 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 244 KB

Real-life comparison of DPP4-inhibitors

Real-life comparison of DPP4-inhibitors with conventional oral antidiabetics as add-on therapy to metformin in elderly patients with type 2 diabetes: The HYPOCRAS study

✍ A. Penfornis; I. Bourdel-Marchasson; S. Quere; S. Dejager 📂 Article 📅 2012 🏛 Masson Editeur 🌐 French ⚖ 309 KB

Real-life comparison of DPP4-inhibitors

Real-life comparison of DPP4-inhibitors with conventional oral antidiabetics as add-on therapy to metformin in elderly patients with type 2 diabetes: The HYPOCRAS study

✍ A. Penfornis; I. Bourdel-Marchasson; S. Quere; S. Dejager 📂 Article 📅 2012 🏛 Masson Editeur 🌐 French ⚖ 309 KB

## Aim: Despite half of all type 2 diabetes mellitus (t2dm) patients being over 65 and treatment being complicated by an elevated risk of iatrogenic hypoglycaemia, information about antidiabetic treatment is scarce in this age group. this prospective observational study compares dpp4-inhibitors (dp